GIT1 and neoplasm: Although both lymph node and primary biopsies showed a similar frequency of high GIT1 expression (29% vs 34% respectively), the percentage of lymph nodes with moderate GIT1 expression was lower than that of primary tumours (29% vs 41% respectively), and 43% of lymph node samples were negative for GIT1 compared with 25% of primary tumour samples (Table 3).